Home

Contact Us

 
 
 


 
 



Health and Medical Guide to Diagnostic Tests

Mammography

Health information topics about Mammography:

Anatomy/Physiology

    1. Atlas of the Body: The Breast -- Disorders
    American Medical Association
    http://www.medem.com/MedLB/article_detaillb.cfm?article_ID=ZZZ3F9G56JC&sub_...

Clinical Trials

    1. ClinicalTrials.gov: Mammography
    National Institutes of Health
    http://clinicaltrials.gov/search/intervention=mammography&recruiting=true

    2. Digital Mammographic Imaging Screening Trial
    National Cancer Institute
    http://www.cancer.gov/dmist/what-is-dmist

Directories

    1. National Breast and Cervical Cancer Early Detectio
    National Center for Chronic Disease Prevention and Health Promotion
    http://www.cdc.gov/cancer/nbccedp/contacts.htm

    2. FDA Certified Mammography Facilities
    Center for Devices and Radiological Health, Food and Drug Administration
    http://www.fda.gov/cdrh/mammography/certified.html

    3. American College of Radiology Accredited Facilitie
    American College of Radiology
    http://apps2.acr.org/lib/afw/afw-search.php

Financial Issues

    1. Breast Cancer Screening (Mammograms)
    Centers for Medicare & Medicaid Services
    http://www.medicare.gov/health/mammography.asp

Law and Policy

    1. Frequently Asked Questions about Mammography Quali
    Center for Drug Evaluation and Research
    http://www.fda.gov/cdrh/mammography/cons-faq2.html

National Institutes of Health

    1. Get a Mammogram: Do It for Yourself, Do It for You
    National Cancer Institute
    http://cancer.gov/images/Documents/68432989-7c99-4e56-8352-c813d5ef3422/eng...

    2. Screening Mammograms
    National Cancer Institute
    http://cis.nci.nih.gov/fact/5_28.htm

    3. Mammograms: Not Just Once, but for a Lifetime
    National Cancer Institute
    http://www.cancer.gov/templates/doc.aspx?viewid=946804B6-8B6F-4CD4-B692-ED7...

Organizations

    1. American Cancer Society

    http://www.cancer.org/

    2. National Cancer Institute

    http://www.cancer.gov/

Other Languages

    1. Get a Mammogram: Do It for Yourself, Do It for You
    National Cancer Institute
    http://cancer.gov/images/Documents/68432989-7c99-4e56-8352-c813d5ef3422/tag...

    2. Get a Mammogram: Do It for Yourself, Do It for You
    National Cancer Institute
    http://cancer.gov/images/Documents/68432989-7c99-4e56-8352-c813d5ef3422/Vie...

    3. Get a Mammogram: Do It for Yourself, Do It for You
    National Cancer Institute
    http://cancer.gov/images/Documents/68432989-7c99-4e56-8352-c813d5ef3422/Chi...

Overviews

    1. Mammography
    American College of Radiology, Radiological Society of North America
    http://www.radiologyinfo.org/content/mammogram.htm

    2. Mammograms
    Breastcancer.org
    http://www.breastcancer.org/testing_mammogram.html

    3. Mammograms and Breast Cancer
    Food and Drug Administration
    http://www.fda.gov/opacom/lowlit/mammo.html

Pictures/Diagrams

    1. Pictures of Diagnosis (Breast Cancer)
    Breastcancer.org
    http://www.breastcancer.org/diagnosis_picture.html

Prevention/Screening

    1. Mammography: Screening Tool for Breast Cancer
    Mayo Foundation for Medical Education and Research
    http://www.mayoclinic.com/invoke.cfm?id=WO00023

Related Issues

    1. Mammography Screening Effective for Women with Bre
    Breastcancer.org
    http://www.breastcancer.org/breast_implant_mammogram.html

    2. Can Breastfeeding Mothers Get Mammograms?
    La Leche League International
    http://www.lalecheleague.org/FAQ/mammogram.html

    3. Breast Implants: Do They Interfere with Breast Exa
    Mayo Foundation for Medical Education and Research
    http://www.mayoclinic.com/invoke.cfm?id=AN00419

Research

    1. Women Skip Lifesaving Mammograms
    American Cancer Society
    http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Women_Skip_Lifesaving_Ma...

    2. Relationship of Health Status and Use of Mammograp
    American College of Physicians
    http://www.annals.org/cgi/content/full/140/9/I-18

    3. Mammograms: Room for Improvement Cited
    American Cancer Society
    http://www.cancer.org/docroot/NWS/content/NWS_2_1x_Mammograms_Room_for_Impr...

    4. Cost-Effectiveness of Mammography in Women Older t
    American College of Physicians
    http://www.annals.org/cgi/content/full/139/10/I-34

Specific Conditions

    1. Digital Tomosynthesis: A Better Mammogram?
    Mayo Foundation for Medical Education and Research
    http://www.mayoclinic.com/invoke.cfm?id=AN00807

    2. Updated Breast Cancer Screening Guidelines Release
    American Cancer Society
    http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Updated_Breast_Cancer_Sc...

    3. Mammography and Other Breast Imaging Procedures
    American Cancer Society
    http://www.cancer.org/docroot/cri/content/cri_2_6x_mammography_and_other_br...

    4. Frequently Asked Questions about Digital Mammograp
    Food and Drug Administration
    http://www.fda.gov/cdrh/mammography/dig-faq.html

Statistics

    1. FASTATS: Mammography
    National Center for Health Statistics
    http://www.cdc.gov/nchs/fastats/mamogram.htm


 



Clinical Trials / Drug Trials News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

5 Sep 2010 at 3:00am
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®...
4 Sep 2010 at 3:00am
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S...
3 Sep 2010 at 6:00am
Results from studies related to Optimer Pharmaceuticals, Inc.'s (Nasdaq: OPTR) lead developmental product candidate, fidaxomicin, will be presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at the Boston Convention and Exhibition Center in Boston on September 12-15, 2010...
3 Sep 2010 at 4:00am
Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada...
3 Sep 2010 at 4:00am
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA)...
3 Sep 2010 at 4:00am
Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo...
3 Sep 2010 at 4:00am
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®...
2 Sep 2010 at 6:00am
Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, "Eisai") announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease...
2 Sep 2010 at 6:00am
Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat. Around 60 patients with advanced pancreatic cancer will be recruited for the first Phase I/IIclinical trial of a drug called MK-0752** in this disease...
2 Sep 2010 at 5:00am
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study...
2 Sep 2010 at 4:00am
QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients...
2 Sep 2010 at 4:00am
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing...
2 Sep 2010 at 4:00am
A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)...
2 Sep 2010 at 4:00am
ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D...
2 Sep 2010 at 4:00am
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint...

 

 

HealthBusinessBuilder.com Build your Health Business Fast!

 

Copyright 2009 emedicaltest.com. All Rights Reserved. emedicaltest.com is not affiliated with WebMD